Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Jun 25, 2026, 6:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 659 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Children With Autism Clear all
Completed No phase listed Observational Accepts healthy volunteers

Studies of Brain and Body Interaction

NCT03672266
View directory record Official record
Conditions
Autistic Disorders Spectrum, Adhd, Asperger Syndrome, Alzheimer Disease, Parkinson, Tremor Essential, Dementia, Alzheimer Type, Lewy Body Dementia With Behavioral Disturbance (Disorder), Dementia With Lewy Bodies, Dementia Frontal
Interventions
Not listed
Lead sponsor
Rutgers University
Other
Eligibility
Not listed
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2025
U.S. locations
1
States / cities
Piscataway, New Jersey
Source: ClinicalTrials.gov public record
Updated Apr 28, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

NCT00337571
View directory record Official record
Conditions
Behavioral Symptoms, Autistic Disorder
Interventions
Aripiprazole, Placebo
Drug
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Eligibility
6 Years to 17 Years
Enrollment
218 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2008
U.S. locations
31
States / cities
Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 28 more
Source: ClinicalTrials.gov public record
Updated May 12, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional

A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander

NCT03814902
View directory record Official record
Conditions
Autism Spectrum Disorder, Wandering Behavior
Interventions
Electronic Tracking Device
Device
Lead sponsor
Northwell Health
Other
Eligibility
18 Years and older
Enrollment
31 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019
U.S. locations
1
States / cities
New Hyde Park, New York
Source: ClinicalTrials.gov public record
Updated Jan 4, 2021 · Synced Jun 25, 2026, 6:41 PM EDT
Terminated Not applicable Interventional

Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care

NCT05456139
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Treatment as Usual, Early Social Interaction Mobile Coaching (ESI-MC)
Behavioral
Lead sponsor
Florida State University
Other
Eligibility
15 Months to 20 Months
Enrollment
52 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
8
States / cities
Los Angeles, California • Tallahassee, Florida • Atlanta, Georgia + 5 more
Source: ClinicalTrials.gov public record
Updated Feb 16, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Recruiting Phase 4 Interventional

AWARE: Management of ADHD in Autism Spectrum Disorder

NCT05916339
View directory record Official record
Conditions
ADHD, Autism Spectrum Disorder
Interventions
Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
Drug
Lead sponsor
Daniel Coury
Other
Eligibility
4 Years to 17 Years
Enrollment
500 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2027
U.S. locations
10
States / cities
Irvine, California • Los Angeles, California • Portland, Maine + 7 more
Source: ClinicalTrials.gov public record
Updated Oct 28, 2025 · Synced Jun 25, 2026, 6:41 PM EDT
Recruiting No phase listed Observational

Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency

NCT05600946
View directory record Official record
Conditions
Cognitive Disorder, Metabolic Disease, Autism Spectrum Disorder
Interventions
Not listed
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Eligibility
2 Years to 40 Years · Male only
Enrollment
19 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2026
U.S. locations
1
States / cities
Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Jun 3, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Autism Spectrum Disorders (ASD) Characterization Study

NCT00801554
View directory record Official record
Conditions
Autism Spectrum Disorders
Interventions
Not listed
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
6 Years to 60 Years
Enrollment
26 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2010
U.S. locations
1
States / cities
Cambridge, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 21, 2013 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 2 Interventional

A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)

NCT01793441
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Placebo, RG7314
Drug
Lead sponsor
Hoffmann-La Roche
Industry
Eligibility
18 Years to 45 Years · Male only
Enrollment
223 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2016
U.S. locations
56
States / cities
Phoenix, Arizona • Sacramento, California • San Diego, California + 26 more
Source: ClinicalTrials.gov public record
Updated Feb 2, 2017 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional

A Crisis Prevention Program for Youth With Autism

NCT05681143
View directory record Official record
Conditions
Autism Spectrum Disorder, Behavior Problem
Interventions
Crisis Prevention Arm, Control
Other
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Other
Eligibility
3 Years to 17 Years
Enrollment
61 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023
U.S. locations
1
States / cities
Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Jan 2, 2024 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional Results available

Intensive Intervention for Toddlers With Autism (EARLY STEPS)

NCT00698997
View directory record Official record
Conditions
Autism, Autism Spectrum Disorder
Interventions
Early Start Denver Model, Standard community care
Behavioral
Lead sponsor
University of California, Davis
Other
Eligibility
12 Months to 24 Months
Enrollment
118 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2013
U.S. locations
1
States / cities
Sacramento, California
Source: ClinicalTrials.gov public record
Updated Feb 16, 2020 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Facing Your Fears in Schools: Implementing a CBT Program for Students With ASD or Other Special Learning Needs

NCT03685474
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Facing Your Fears - School Based, Usual Care
Behavioral
Lead sponsor
University of Colorado, Denver
Other
Eligibility
8 Years to 14 Years
Enrollment
389 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2020
U.S. locations
1
States / cities
Aurora, Colorado
Source: ClinicalTrials.gov public record
Updated Sep 29, 2021 · Synced Jun 25, 2026, 6:41 PM EDT
Terminated Phase 1Phase 2 Interventional Accepts healthy volunteers

Investigation of Mechanisms of Action in Superpower Glass

NCT04049981
View directory record Official record
Conditions
Autism Spectrum Disorder, Autism
Interventions
Superpower Glass
Device
Lead sponsor
Stanford University
Other
Eligibility
4 Years to 8 Years
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2020
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Sep 4, 2023 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Early Phase 1 Interventional Accepts healthy volunteers Results available

Effects of Drugs on Responses to Brain and Emotional Processes

NCT04053036
View directory record Official record
Conditions
Autism Spectrum Disorder, Healthy
Interventions
MDMA, Placebo oral tablet
Drug
Lead sponsor
University of Chicago
Other
Eligibility
21 Years to 40 Years
Enrollment
22 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2021
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Nov 24, 2024 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 1 Interventional

hCT-MSC Infusion in Adults With Autism Spectrum Disorder

NCT04484077
View directory record Official record
Conditions
Autism Spectrum Disorder, Autism
Interventions
hCT-MSC
Biological
Lead sponsor
Joanne Kurtzberg, MD
Other
Eligibility
18 Years to 34 Years
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2024
U.S. locations
1
States / cities
Durham, North Carolina
Source: ClinicalTrials.gov public record
Updated Jul 22, 2024 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)

NCT05192109
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Overheard Speech, Addressed Speech
Behavioral
Lead sponsor
New York University
Other
Eligibility
18 Months to 71 Months
Enrollment
342 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2024
U.S. locations
2
States / cities
Boston, Massachusetts • New York, New York
Source: ClinicalTrials.gov public record
Updated Mar 31, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 4 Interventional Accepts healthy volunteers

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

NCT04903353
View directory record Official record
Conditions
Weight Gain, Autism Spectrum Disorder, Medication Side Effect
Interventions
Comparison of Risperidone and Aripiprazole
Drug
Lead sponsor
Vanderbilt University Medical Center
Other
Eligibility
Up to 17 Years
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2025
U.S. locations
1
States / cities
Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Apr 12, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Recruiting No phase listed Observational

Developing Brain, Impulsivity and Compulsivity

NCT04631042
View directory record Official record
Conditions
Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder
Interventions
Not listed
Lead sponsor
National Institute of Mental Health (NIMH)
NIH
Eligibility
6 Years to 80 Years
Enrollment
1,100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2031
U.S. locations
1
States / cities
Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Jun 24, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

NCT00332241
View directory record Official record
Conditions
Autistic Disorder
Interventions
Aripiprazole, Placebo
Drug
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Eligibility
6 Years to 17 Years
Enrollment
98 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2008
U.S. locations
9
States / cities
Boca Raton, Florida • Atlanta, Georgia • Louisville, Kentucky + 6 more
Source: ClinicalTrials.gov public record
Updated May 12, 2026 · Synced Jun 25, 2026, 6:41 PM EDT
Not listed Phase 3 Interventional

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

NCT05361707
View directory record Official record
Conditions
Autism Spectrum Disorder, Sleep Disorder, Neurological Disorder, Sleep Disturbance
Interventions
Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension
Drug
Lead sponsor
Vanda Pharmaceuticals
Industry
Eligibility
2 Years to 65 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2025
U.S. locations
5
States / cities
San Jose, California • San Leandro, California • Santa Monica, California + 2 more
Source: ClinicalTrials.gov public record
Updated Mar 20, 2024 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional Results available

Mindfulness for Parents of Children With Autism Spectrum Disorder Autism Spectrum Disorder

NCT03459625
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Mindfulness-Based Stress Reduction (MSBR), Psychoeducational Support Group (PE)
Behavioral
Lead sponsor
Loma Linda University
Other
Eligibility
3 Years to 5 Years
Enrollment
118 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2022
U.S. locations
1
States / cities
Loma Linda, California
Source: ClinicalTrials.gov public record
Updated Nov 12, 2023 · Synced Jun 25, 2026, 6:41 PM EDT
Recruiting Not applicable Interventional

Peer Interventions for Preschoolers With Autism

NCT05799599
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Stay-Play-Talk Basic, Stay-Play-Talk Plus, Stay-Play-Talk Advanced
Behavioral
Lead sponsor
University of Kansas
Other
Eligibility
3 Years to 6 Years
Enrollment
132 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2028
U.S. locations
2
States / cities
Kansas City, Kansas • Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Mar 27, 2024 · Synced Jun 25, 2026, 6:41 PM EDT
Not yet recruiting Not applicable Interventional

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

NCT07170163
View directory record Official record
Conditions
Autism Spectrum Disorder (ASD)
Interventions
¡Iniciando! mHealth App
Behavioral
Lead sponsor
The University of Texas Health Science Center, Houston
Other
Eligibility
18 Years to 25 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Sep 11, 2025 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Dental Fear Among Children With Autism Spectrum Disorders

NCT01784276
View directory record Official record
Conditions
Dental Fear
Interventions
Video
Behavioral
Lead sponsor
Boston Children's Hospital
Other
Eligibility
7 Years to 17 Years
Enrollment
80 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010 – 2012
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Feb 4, 2013 · Synced Jun 25, 2026, 6:41 PM EDT
Completed Phase 2 Interventional

CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS

NCT00280670
View directory record Official record
Conditions
Autistic Disorder, Asperger Syndrome, Anxiety Disorders
Interventions
Cognitive-behavioral therapy
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
7 Years to 11 Years
Enrollment
20 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2009
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Apr 1, 2012 · Synced Jun 25, 2026, 6:41 PM EDT